Increases Deal Size to $600 Million.
Churchill Capital just filed an amended prospectus around 1:45PM today, increasing their deal size to $600 million. This most likely means pricing is off tonight since the $150 million increase is larger than a 20% upsize and therefore, it does not qualify for rule 462(b).
However, stranger things have happened and maybe Citigroup can get this through the SEC today and still price tonight.
Additionally, B. Riley FBR has been added as an underwriter. This is a nice cover for B. Riley and they’ll certainly be able to help out with rounding up a minimum of 350 round lot shareholders needed to comply with a NYSE listing.
Updated Summary of Terms below:
- Focus: Technology / Software
- Size: $600 million
- 100% held in trust ($10.00 per share)
- At-risk Capital: $16.5 million (16,500,000 warrants at $1.00)
- $10.00 unit comprised of one share of Class A Common Stock + 1/2 of one Warrant
- 24 months to complete an acquisition
- Limitation on redemption rights: 15%
- Warrant call (cash/cashless): >$18.00
- Underwriter fees: 2.0% + 3.5% deferred
- Citigroup: sole bookrunner; co-manager: B. Riley FBR
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...